- Poseida Therapeutics Announces Key Additions to Immuno-Oncology Scientific Advisory Board
- Poseida Therapeutics to Present at BofA Securities 2021 Virtual Health Care Conference
- Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 2021 Annual Meeting
- Poseida Therapeutics to Present at Upcoming Virtual Investor Conferences
- Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board
- Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020
- Poseida Therapeutics Provides Update on Key Programs and Developments During R&D Day
- Poseida Therapeutics to Host Virtual R&D Day on February 24, 2021
Poseida Therapeutics Inc (PSTX:NSQ) closed at 7.96, 4.33% above its 52-week low of 7.63, set on Aug 24, 2020.
7.63Aug 24 202017.62Jul 17 2020
Markit short selling activity
|Market cap||538.08m USD|
|EPS (TTM)||-2.17 |
Data delayed at least 15 minutes, as of May 10 2021 21:00 BST.